<code id='4533AF42EE'></code><style id='4533AF42EE'></style>
    • <acronym id='4533AF42EE'></acronym>
      <center id='4533AF42EE'><center id='4533AF42EE'><tfoot id='4533AF42EE'></tfoot></center><abbr id='4533AF42EE'><dir id='4533AF42EE'><tfoot id='4533AF42EE'></tfoot><noframes id='4533AF42EE'>

    • <optgroup id='4533AF42EE'><strike id='4533AF42EE'><sup id='4533AF42EE'></sup></strike><code id='4533AF42EE'></code></optgroup>
        1. <b id='4533AF42EE'><label id='4533AF42EE'><select id='4533AF42EE'><dt id='4533AF42EE'><span id='4533AF42EE'></span></dt></select></label></b><u id='4533AF42EE'></u>
          <i id='4533AF42EE'><strike id='4533AF42EE'><tt id='4533AF42EE'><pre id='4533AF42EE'></pre></tt></strike></i>

          Home / comprehensive / focus

          focus


          focus

          author:focus    Page View:4696
          King Street Properties’ Pathway Devens campus. -- biotech coverage from STAT
          Pat Greenhouse/Globe Staff

          MORRISVILLE, N.C. — Ten minutes from the Raleigh airport, the future of biotech is under construction.

          On either side of a new stretch of four-lane highway sit two $1 billion biomanufacturing campuses, which will bring a combined 2.5 million square feet of research and development and advanced manufacturing space to a region that has become the No. 1 place where North America makes prescription drugs.

          advertisement

          One campus, called Pathway Triangle, is being built by a developer from Boston, King Street Properties. King Street — which has projects in Cambridge, Waltham, Allston, and Lexington — is building a similarly vast biomanufacturing campus in Devens. But these days it also sees a land of opportunity 700 miles to the south, in North Carolina.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In